Page 2 - 340b Program News Today

Health systems participating in the drug discount program did not have fewer disparities than hospitals not participating.

Government should revamp 340B drug pricing program

340B program controversy. Supreme Court decision Centers for Medicare & Medicaid Services’ CMS payment cuts to 340B hospitals under Outpatient Prospective Payment System OPPS illegal. Manufacturers, contract pharmacies, Health Resources and Services Administration HRSA continues.

Our combined services assist with the compliance, technology, and business challenges felt across the spectrum of 340B Entities....

Supreme Court issued American Hospital Association v. Becerra decision on whether Centers for Medicare & Medicaid Services had authority to make certain payment cuts to 340B Program safety net hospitals for drug reimbursement.

Supreme Court issued American Hospital Association et. al. v. Becerra opinion overturning massive reimbursement reductions in 340B drug pricing program. 340B Program requires drug manufacturers to provide outpatient drugs to participating providers at discounted rates.

Congress was in recess during the Memorial Day holiday week, to return June 6. House Judiciary Committee held markup of Protecting Our Kids Act, gun control bills introduced by Chairman Jerrold Nadler in response to mass shootings.

Fourth Circuit addressed issue of which persons qualify as patients of a 340B program participating entity. Court-ordered filings in ongoing litigation between Genesis HealthCare Inc, 340B covered entity, and Department of Health and Human Services, Health Resources and Services Administration HRSA

Fourth Circuit addressed issue of which persons qualify as patients of a 340B program participating entity. Court-ordered filings in ongoing litigation between Genesis HealthCare Inc, 340B covered entity, and Department of Health and Human Services, Health Resources and Services Administration HRSA

Supreme Court heard oral arguments involving a 340B Drug Pricing Program matter in American Hospital Association v. Becerra. The Justices questioned whether CMS acted within its authority to implement Medicare reimbursement cuts for certain separately reimbursable 340B drugs